Announcements Trials
Browse Landscape

Phase

Phase 2 24Phase 1 5Phase 1/2 4Phase 2/3 3

Status

Unknown 10Completed 4Not yet recruiting 3Terminated 2Active not recruiting 2Recruiting 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Thoracic 2Sarcoma 1Gastrointestinal 1

Conditions

Stomach Neoplasms 1Sarcoma 1Neoplasm Metastasis 1Carcinoma, Non-Small-Cell Lung 1Adenocarcinoma of Lung 1

Interventions

Cyclophosphamide 142Gemcitabine 129Paclitaxel 125Radiotherapy 119Carboplatin 112Cisplatin 111pembrolizumab 110Nivolumab 106Docetaxel 90Rituximab 86Lenalidomide 77Dexamethasone 76Cytarabine 69Bevacizumab 64Fluorouracil 63Etoposide 63Oxaliplatin 62Filgrastim 59Peripheral Blood Stem Cell Transplantation 58Everolimus 58Capecitabine 58fludarabine phosphate 57Doxorubicin 56Temozolomide 55Prednisone 54Irinotecan 53Cetuximab 50fludarabine 48Ipilimumab 48Erlotinib Hydrochloride 48

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 1/2 × Completed × anlotinib × Clear all
NCT05301764 2026-05-20

A Study of LVGN6051 Combined With Anlotinib in Patient With Soft Tissue Sarcoma

Lyvgen Biopharma Holdings Limited

Phase 1/2 Completed
39 enrolled
Sarcoma

Sarcoma

NCT04963088 2025-06-26

TALENT

The First Affiliated Hospital with Nanjing Medical University

Phase 1/2 Completed
65 enrolled
Gastrointestinal

Stomach Neoplasms

NCT04770688 2024-08-15

AUTOMAN

Shanghai Chest Hospital

Phase 1/2 Completed
25 enrolled
Thoracic

Adenocarcinoma of Lung, Neoplasm Metastasis

NCT04507906 2022-06-28

Nivolumab Combined With Anlotinib as Re-challenge Treatment in Advanced NSCLC

Shanghai Chest Hospital

Phase 1/2 Completed
21 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡